Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Thoracic 1Lymphoid 1Head & Neck 1

Conditions

Glioblastoma 14Brain Neoplasms 12Glioma 11Astrocytoma 9Meningioma 7Central Nervous System Neoplasms 7Gliosarcoma 6Diffuse Intrinsic Pontine Glioma 6Recurrence 4Neurofibromatosis 2 4Tuberous Sclerosis 3Pheochromocytoma 3Paraganglioma 3Neuroma, Acoustic 3Rhabdomyosarcoma 2Oligodendroglioma 2Neurofibromatosis 1 2Neuroendocrine Tumors 2Neoplasms 2Hereditary Sensory and Autonomic Neuropathies 2von Hippel-Lindau Disease 1Zollinger-Ellison Syndrome 1Vestibulocochlear Nerve Diseases 1Tuberous Sclerosis 2 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Seizures 1Sarcoma 1Salivary Gland Neoplasms 1

Interventions

Everolimus 2lorlatinib 1liposomal doxorubicin 1encorafenib 1binimetinib 1Taxes 1Radiotherapy 1Paclitaxel 1Lomustine 1Irinotecan 1Gemcitabine 1Doxorubicin 1Cetuximab 1Carboplatin 1Albumin-Bound Paclitaxel 1AZD1390 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hereditary Sensory and Autonomic Neuropathies × Everolimus × CNS × Clear all
NCT00790400 2017-02-17

EXIST-2

Novartis

Phase 3 Completed
118 enrolled 15 charts
CNS

Tuberous Sclerosis 2, Astrocytoma, Hereditary Sensory and Autonomic Neuropathies, Seizures, Tuberous Sclerosis, Lymphangioleiomyomatosis, Angiomyolipoma

NCT00411619 2014-10-20

Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex

Children's Hospital Medical Center, Cincinnati

Phase 1/2 Completed
28 enrolled 7 charts
CNS

Astrocytoma, Hereditary Sensory and Autonomic Neuropathies, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡